LONZA GROUP AG UNSP/ADR (LZAGY) Stock Price, Quote & AI Analysis

Live LZAGY stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for LONZA GROUP AG UNSP/ADR.

TradeVae provides AI-driven analysis and real-time market intelligence for LONZA GROUP AG UNSP/ADR (LZAGY), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

L
LZAGY
LONZA GROUP AG UNSP/ADR
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
52W Range
$58.53 - $74.36
P/E Ratio
-
EPS
-
Dividend Yield
57.32%
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

LONZA GROUP AG UNSP/ADR's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

LONZA GROUP AG UNSP/ADR Overview

Company information

Company Overview

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland. LZAGY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Company Details
Market Cap
$48.54B
Shares Outstanding
702,295,861
CEO
Wolfgang Wienand
Exchange
OTC Link

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

LONZA GROUP AG UNSP/ADR Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...